Skip to main content

Biologic

Biologic

A therapeutic calcium channel blocking antibody for cancer

Development of a novel, phosphospecific alpha-synuclein antibody as a therapeutic for MSA​

Developing an ADC for treatment of glioma

Developing Catalytically Inactive CELA2A as a First-in-Class Therapy for Diabetes

First-in-class Nectin-2 targeting ADC for solid tumors

Nanobody MET CAR for solid tumors

Liver Endothelial Vascular Reprogramming: a Therapeutic Alternative to Liver Transplantation

Subscribe to Biologic